Melanocortin Receptor Agonist Comparison
Melanotan 1 (MT1) differs significantly from related compounds in potency, duration, and side effect profiles, requiring distinct dosing approaches for research applications. Comparative analysis with similar melanocortin receptor agonists demonstrates unique
This comparison does not assign a generated winner or score.
- Melanotan 1 (MT1) differs significantly from related compounds in potency, duration, and side effect profiles, requiring distinct dosing approaches for research applications. Comparative analysis with similar melanocortin receptor agonists demonstrates unique pharmacological characteristics.
- Melanotan 1
- 0.16-0.25 mg/kg
- Daily
- 33-41 min
- MC1R selective
- Melanotan 2
- 0.5-2.0 mg
- 2.5-3 hours
- MC1R/MC4R activity
- PT-141
- 1.75 mg
- As needed
- 2.7 hours
- MC4R selective
- α-MSH
- 1-10 mg
- Multiple daily
- IV/SC
- 7-20 min
- Endogenous hormone